Showing results (2391-2400 of 8,031) with videos related to
Sort By:
Pageof 804
Current Medicinal Chemistry|September 1, 2022
Renal Effects of Empagliflozin in Patients with Type 2 Diabetes MellitusHabib Yaribeygi, Mina Maleki, Thozhukat Sathyapalan, et al.Current Medicinal Chemistry|January 7, 2022
Cucurbitacins and the Immune System: Update in Research on Anti- inflammatory, Antioxidant, and Immunomodulatory MechanismsGeovana F Guedes Silvestre, Renally Pereira de Lucena, Harley da Silva AlvesCurrent Medicinal Chemistry|December 9, 2021
Extracellular Vesicles as Innovative Tools for Assessing Adverse Effects of Immunosuppressant DrugsMarianna Lucafò, Serena De Biasi, Debora Curci, et al.Current Medicinal Chemistry|July 17, 2015
MicroRNAs Determining Inflammation as Novel Biomarkers and Potential Therapeutic TargetsAthanassios Kotsinas, Fragkiska Sigala, Spiros D Garbis, et al.Current Medicinal Chemistry|August 3, 2016
Nitric Oxide-Releasing Biomaterials for Biomedical ApplicationsXin Zhou, Jimin Zhang, Guowei Feng, et al.Current Medicinal Chemistry|July 29, 2016
Immunoregulatory and Effector Activities of Nitric Oxide and Reactive Nitrogen Species in CancerCinzia Fionda, Maria Pia Abruzzese, Angela Santoni, et al.Current Medicinal Chemistry|August 24, 2025
Diverse Development Approaches for Xanthine Oxidase Inhibitors: Synthetic Chemistry, Natural Product Chemistry, and Drug RepositioningZhihua Xing, Wen Jiang, Yue Xu, et al.Current Medicinal Chemistry|August 24, 2025
Romosozumab's Effect on Bone Mineral Density in Patients with Osteoporosis: A Systematic Review and Meta-AnalysisHooman Yahyazadeh, Tahereh Farkhondeh, Abolfazl Bagherifard, et al.Current Medicinal Chemistry|September 5, 2025
PROTACs Targeting Molecular Targets in Triple-Negative Breast CancerGyas Khan, Sarfaraz Ahmad, Md Sadique HussainCurrent Medicinal Chemistry|June 5, 2020
New Perspectives in the Pharmacological Potential of Naringin in MedicineMaría Angélica Rivoira, Valeria Rodriguez, Germán Talamoni, et al.Pageof 804